作者: G. Mathé , L. M. van Putten
DOI: 10.1007/BF00253141
关键词:
摘要: In this short review attention is drawn to promising new drugs and information on old drugs. The may concern clinical results or pertain preclinical data. selection of arbitrary no claim completeness listing made. Hormones have not been considered. for which chemotherapy poor today, such as neuroblastoma, uterus cervix cancer, larynx tumours, chronic myeloid leukaemia blastic crisis. De Barbieri et al. (1977) are developing a large series di-(2-chloroethyl) glycopeptides, some give resuits sarcoma 180 L1210 leukaemia.